Open AccessAripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial
Author(s) -
Lucía Garrido-Sánchez,
Marcos GómezRevuelta,
Víctor OrtizGarcía de la Foz,
José María PelayoTerán,
María Juncal-Ruiz,
Miguel RuizVeguilla,
Jacqueline Mayoral-van Son,
Rosa AyesaArriola,
Javier VázquezBourgon,
Benedicto CrespoFacorro
Publication year - 2022
Publication title -
the international journal of neuropsychopharmacology
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyac047
Subject(s) - aripiprazole , risperidone , discontinuation , randomized controlled trial , antipsychotic , medicine , adverse effect , psychology , olanzapine , psychiatry , schizophrenia (object oriented programming)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom